QWINT-1: Weekly Insulin Efsitora Matches Daily Insulin in Type 2 Diabetes

A new study reveals once-weekly efsitora alfa effectively lowers blood glucose in type 2 diabetes, simplifying insulin therapy and enhancing patient adherence.

Read the full article here

Source: www.hcplive.com

Categories: General Medicine News

Tags: Type2Diabetes,insulin,ADASciSessions

Tweets with this article

MD Mag

For people with #Type2Diabetes starting insulin therapy, a once-weekly insulin named efsitora alfa is just as effective in lowering blood glucose as a daily regimen with daily basal #insulin, according to a new study. https://t.co/5s93Kb45DX #ADASciSessions

Personalized Diabetes Prevention: Insights from 15 Years of the VA MOVE! Program, with Qiaochu Xue, PhD, MPH

Xue discussed her research developing a personalized prediction algorithm for predicting responders to a DPP-style intervention.

MD Mag June 23, 2025

ADA 2025: CagriSema Demonstrates Dual Benefit in Obesity and Type 2 Diabetes

CagriSema shows weight loss results in recent trials comparable to existing interventions.

MD Mag June 23, 2025

Universal Semaglutide Access Could Save 28 Million Lives in 5 Years, Study Finds

A global study reveals that universal access to semaglutide could save 28 million lives and significantly reduce obesity and diabetes worldwide.

MD Mag June 23, 2025

Validating Intermittent Fasting for T2D, with Felicia Steger, PhD, RD

Steger discussed findings from a 6-month lifestyle investigating TRE+ER and IER.

MD Mag June 23, 2025